The Profile of Plasma Free Amino Acids in Type 2 Diabetes Mellitus with Insulin Resistance: Association with Microalbuminuria and Macroalbuminuria
Altered plasma levels of branched-chain amino acids (BCAAs) and aromatic amino acids (AAAs) may predict the development of insulin resistance and other type 2 diabetes mellitus (T2DM) associated comorbidities. To elucidate the role of plasma free amino acids (PFAAs) profile as a biomarker for early...
Gespeichert in:
Veröffentlicht in: | Applied biochemistry and biotechnology 2019-07, Vol.188 (3), p.854-867 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 867 |
---|---|
container_issue | 3 |
container_start_page | 854 |
container_title | Applied biochemistry and biotechnology |
container_volume | 188 |
creator | Saleem, Tahia Dahpy, Marwa Ezzat, Ghada Abdelrahman, Ghada Abdel-Aziz, Essam Farghaly, Rania |
description | Altered plasma levels of branched-chain amino acids (BCAAs) and aromatic amino acids (AAAs) may predict the development of insulin resistance and other type 2 diabetes mellitus (T2DM) associated comorbidities. To elucidate the role of plasma free amino acids (PFAAs) profile as a biomarker for early detection of diabetic kidney disease, quantitative measurement of PFAAs profile was determined for 90 T2DM subjects, 30 were free of nephropathy, 30 with microalbuminuria, 30 with macroalbuminuria, and in addition to 30 healthy controls. The plasma levels of valine, leucine, isoleucine, phenylalanine, citrulline, and total BCAAs were significantly increased in diabetic normoalbuminuria group when compared to controls. However, the total BCAAs level was significantly decreased in diabetic patients with micro and macroalbuminuria. Other amino acid plasma levels as tyrosine, arginine, ornithine, glycine, and the total AAAs level were significantly decreased in all diabetic subgroups compared to controls. Significant positive correlations between total BCAAs, valine, leucine, isoleucine, serum insulin, glucose, and HOMA-IR values in the diabetic normoalbuminuria group were found. The use of altered PFAAs profile as a prognostic factor in T2DM patients at risk for microalbuminuria or macroalbuminuria might reduce or prevent the incidence of end-stage diabetic renal disease. |
doi_str_mv | 10.1007/s12010-019-02956-9 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2179502183</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2179502183</sourcerecordid><originalsourceid>FETCH-LOGICAL-c412t-a7288febf07923840106ece59ffee7a1d0e17ccd88968c57b0fa9348acefacd63</originalsourceid><addsrcrecordid>eNp9kc9uFSEUh4nR2Gv1BVwYEjduRoH5A7i7qVab9MbGXNeEYQ6WZgaunJmYvoZPLLdTNbpwRYDv_A6Hj5DnnL3mjMk3yAXjrGJcV0zotqv0A7LhbXu35Q_JhglZV0IofUKeIN4wxoVq5WNyUjPJuoarDfmxvwZ6lZMPI9Dk6dVocbL0PAPQ7RRiolsXBqQh0v3tAaig74LtYQakOxjHMC9Iv4f5ml5EXMZCfQYMONvo4C3dIiYX7BxSXKFdcDnZsV9K8pKDpTYOdGf_PnxKHnk7Ijy7X0_Jl_P3-7OP1eWnDxdn28vKNVzMlZVCKQ-9Z1KLWjXlKzpw0GrvAaTlAwMunRuU0p1yreyZt7pulHXgrRu6-pS8WnMPOX1bAGczBXRlKBshLWgEl7plgqu6oC__QW_SkmN53ZFqmJStPgaKlSrzIGbw5pDDZPOt4cwcjZnVmCnGzJ0xo0vRi_vopZ9g-F3yS1EB6hXAchW_Qv7T-z-xPwHpYaLg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2174077596</pqid></control><display><type>article</type><title>The Profile of Plasma Free Amino Acids in Type 2 Diabetes Mellitus with Insulin Resistance: Association with Microalbuminuria and Macroalbuminuria</title><source>SpringerLink Journals - AutoHoldings</source><creator>Saleem, Tahia ; Dahpy, Marwa ; Ezzat, Ghada ; Abdelrahman, Ghada ; Abdel-Aziz, Essam ; Farghaly, Rania</creator><creatorcontrib>Saleem, Tahia ; Dahpy, Marwa ; Ezzat, Ghada ; Abdelrahman, Ghada ; Abdel-Aziz, Essam ; Farghaly, Rania</creatorcontrib><description>Altered plasma levels of branched-chain amino acids (BCAAs) and aromatic amino acids (AAAs) may predict the development of insulin resistance and other type 2 diabetes mellitus (T2DM) associated comorbidities. To elucidate the role of plasma free amino acids (PFAAs) profile as a biomarker for early detection of diabetic kidney disease, quantitative measurement of PFAAs profile was determined for 90 T2DM subjects, 30 were free of nephropathy, 30 with microalbuminuria, 30 with macroalbuminuria, and in addition to 30 healthy controls. The plasma levels of valine, leucine, isoleucine, phenylalanine, citrulline, and total BCAAs were significantly increased in diabetic normoalbuminuria group when compared to controls. However, the total BCAAs level was significantly decreased in diabetic patients with micro and macroalbuminuria. Other amino acid plasma levels as tyrosine, arginine, ornithine, glycine, and the total AAAs level were significantly decreased in all diabetic subgroups compared to controls. Significant positive correlations between total BCAAs, valine, leucine, isoleucine, serum insulin, glucose, and HOMA-IR values in the diabetic normoalbuminuria group were found. The use of altered PFAAs profile as a prognostic factor in T2DM patients at risk for microalbuminuria or macroalbuminuria might reduce or prevent the incidence of end-stage diabetic renal disease.</description><identifier>ISSN: 0273-2289</identifier><identifier>EISSN: 1559-0291</identifier><identifier>DOI: 10.1007/s12010-019-02956-9</identifier><identifier>PMID: 30706418</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Amino acids ; Arginine ; Biochemistry ; Biomarkers ; Biotechnology ; Chain branching ; Chemistry ; Chemistry and Materials Science ; Citrulline ; Diabetes ; Diabetes mellitus ; Diabetes mellitus (non-insulin dependent) ; End-stage renal disease ; Glycine ; Insulin ; Insulin resistance ; Isoleucine ; Kidney diseases ; Leucine ; Nephropathy ; Ornithine ; Patients ; Phenylalanine ; Plasma ; Plasma levels ; Subgroups ; Tyrosine ; Valine</subject><ispartof>Applied biochemistry and biotechnology, 2019-07, Vol.188 (3), p.854-867</ispartof><rights>Springer Science+Business Media, LLC, part of Springer Nature 2019</rights><rights>Applied Biochemistry and Biotechnology is a copyright of Springer, (2019). All Rights Reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c412t-a7288febf07923840106ece59ffee7a1d0e17ccd88968c57b0fa9348acefacd63</citedby><cites>FETCH-LOGICAL-c412t-a7288febf07923840106ece59ffee7a1d0e17ccd88968c57b0fa9348acefacd63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s12010-019-02956-9$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s12010-019-02956-9$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30706418$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Saleem, Tahia</creatorcontrib><creatorcontrib>Dahpy, Marwa</creatorcontrib><creatorcontrib>Ezzat, Ghada</creatorcontrib><creatorcontrib>Abdelrahman, Ghada</creatorcontrib><creatorcontrib>Abdel-Aziz, Essam</creatorcontrib><creatorcontrib>Farghaly, Rania</creatorcontrib><title>The Profile of Plasma Free Amino Acids in Type 2 Diabetes Mellitus with Insulin Resistance: Association with Microalbuminuria and Macroalbuminuria</title><title>Applied biochemistry and biotechnology</title><addtitle>Appl Biochem Biotechnol</addtitle><addtitle>Appl Biochem Biotechnol</addtitle><description>Altered plasma levels of branched-chain amino acids (BCAAs) and aromatic amino acids (AAAs) may predict the development of insulin resistance and other type 2 diabetes mellitus (T2DM) associated comorbidities. To elucidate the role of plasma free amino acids (PFAAs) profile as a biomarker for early detection of diabetic kidney disease, quantitative measurement of PFAAs profile was determined for 90 T2DM subjects, 30 were free of nephropathy, 30 with microalbuminuria, 30 with macroalbuminuria, and in addition to 30 healthy controls. The plasma levels of valine, leucine, isoleucine, phenylalanine, citrulline, and total BCAAs were significantly increased in diabetic normoalbuminuria group when compared to controls. However, the total BCAAs level was significantly decreased in diabetic patients with micro and macroalbuminuria. Other amino acid plasma levels as tyrosine, arginine, ornithine, glycine, and the total AAAs level were significantly decreased in all diabetic subgroups compared to controls. Significant positive correlations between total BCAAs, valine, leucine, isoleucine, serum insulin, glucose, and HOMA-IR values in the diabetic normoalbuminuria group were found. The use of altered PFAAs profile as a prognostic factor in T2DM patients at risk for microalbuminuria or macroalbuminuria might reduce or prevent the incidence of end-stage diabetic renal disease.</description><subject>Amino acids</subject><subject>Arginine</subject><subject>Biochemistry</subject><subject>Biomarkers</subject><subject>Biotechnology</subject><subject>Chain branching</subject><subject>Chemistry</subject><subject>Chemistry and Materials Science</subject><subject>Citrulline</subject><subject>Diabetes</subject><subject>Diabetes mellitus</subject><subject>Diabetes mellitus (non-insulin dependent)</subject><subject>End-stage renal disease</subject><subject>Glycine</subject><subject>Insulin</subject><subject>Insulin resistance</subject><subject>Isoleucine</subject><subject>Kidney diseases</subject><subject>Leucine</subject><subject>Nephropathy</subject><subject>Ornithine</subject><subject>Patients</subject><subject>Phenylalanine</subject><subject>Plasma</subject><subject>Plasma levels</subject><subject>Subgroups</subject><subject>Tyrosine</subject><subject>Valine</subject><issn>0273-2289</issn><issn>1559-0291</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp9kc9uFSEUh4nR2Gv1BVwYEjduRoH5A7i7qVab9MbGXNeEYQ6WZgaunJmYvoZPLLdTNbpwRYDv_A6Hj5DnnL3mjMk3yAXjrGJcV0zotqv0A7LhbXu35Q_JhglZV0IofUKeIN4wxoVq5WNyUjPJuoarDfmxvwZ6lZMPI9Dk6dVocbL0PAPQ7RRiolsXBqQh0v3tAaig74LtYQakOxjHMC9Iv4f5ml5EXMZCfQYMONvo4C3dIiYX7BxSXKFdcDnZsV9K8pKDpTYOdGf_PnxKHnk7Ijy7X0_Jl_P3-7OP1eWnDxdn28vKNVzMlZVCKQ-9Z1KLWjXlKzpw0GrvAaTlAwMunRuU0p1yreyZt7pulHXgrRu6-pS8WnMPOX1bAGczBXRlKBshLWgEl7plgqu6oC__QW_SkmN53ZFqmJStPgaKlSrzIGbw5pDDZPOt4cwcjZnVmCnGzJ0xo0vRi_vopZ9g-F3yS1EB6hXAchW_Qv7T-z-xPwHpYaLg</recordid><startdate>20190701</startdate><enddate>20190701</enddate><creator>Saleem, Tahia</creator><creator>Dahpy, Marwa</creator><creator>Ezzat, Ghada</creator><creator>Abdelrahman, Ghada</creator><creator>Abdel-Aziz, Essam</creator><creator>Farghaly, Rania</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7ST</scope><scope>7T7</scope><scope>7TM</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>RC3</scope><scope>SOI</scope><scope>7X8</scope></search><sort><creationdate>20190701</creationdate><title>The Profile of Plasma Free Amino Acids in Type 2 Diabetes Mellitus with Insulin Resistance: Association with Microalbuminuria and Macroalbuminuria</title><author>Saleem, Tahia ; Dahpy, Marwa ; Ezzat, Ghada ; Abdelrahman, Ghada ; Abdel-Aziz, Essam ; Farghaly, Rania</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c412t-a7288febf07923840106ece59ffee7a1d0e17ccd88968c57b0fa9348acefacd63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Amino acids</topic><topic>Arginine</topic><topic>Biochemistry</topic><topic>Biomarkers</topic><topic>Biotechnology</topic><topic>Chain branching</topic><topic>Chemistry</topic><topic>Chemistry and Materials Science</topic><topic>Citrulline</topic><topic>Diabetes</topic><topic>Diabetes mellitus</topic><topic>Diabetes mellitus (non-insulin dependent)</topic><topic>End-stage renal disease</topic><topic>Glycine</topic><topic>Insulin</topic><topic>Insulin resistance</topic><topic>Isoleucine</topic><topic>Kidney diseases</topic><topic>Leucine</topic><topic>Nephropathy</topic><topic>Ornithine</topic><topic>Patients</topic><topic>Phenylalanine</topic><topic>Plasma</topic><topic>Plasma levels</topic><topic>Subgroups</topic><topic>Tyrosine</topic><topic>Valine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Saleem, Tahia</creatorcontrib><creatorcontrib>Dahpy, Marwa</creatorcontrib><creatorcontrib>Ezzat, Ghada</creatorcontrib><creatorcontrib>Abdelrahman, Ghada</creatorcontrib><creatorcontrib>Abdel-Aziz, Essam</creatorcontrib><creatorcontrib>Farghaly, Rania</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Environment Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Nucleic Acids Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>Genetics Abstracts</collection><collection>Environment Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Applied biochemistry and biotechnology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Saleem, Tahia</au><au>Dahpy, Marwa</au><au>Ezzat, Ghada</au><au>Abdelrahman, Ghada</au><au>Abdel-Aziz, Essam</au><au>Farghaly, Rania</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Profile of Plasma Free Amino Acids in Type 2 Diabetes Mellitus with Insulin Resistance: Association with Microalbuminuria and Macroalbuminuria</atitle><jtitle>Applied biochemistry and biotechnology</jtitle><stitle>Appl Biochem Biotechnol</stitle><addtitle>Appl Biochem Biotechnol</addtitle><date>2019-07-01</date><risdate>2019</risdate><volume>188</volume><issue>3</issue><spage>854</spage><epage>867</epage><pages>854-867</pages><issn>0273-2289</issn><eissn>1559-0291</eissn><abstract>Altered plasma levels of branched-chain amino acids (BCAAs) and aromatic amino acids (AAAs) may predict the development of insulin resistance and other type 2 diabetes mellitus (T2DM) associated comorbidities. To elucidate the role of plasma free amino acids (PFAAs) profile as a biomarker for early detection of diabetic kidney disease, quantitative measurement of PFAAs profile was determined for 90 T2DM subjects, 30 were free of nephropathy, 30 with microalbuminuria, 30 with macroalbuminuria, and in addition to 30 healthy controls. The plasma levels of valine, leucine, isoleucine, phenylalanine, citrulline, and total BCAAs were significantly increased in diabetic normoalbuminuria group when compared to controls. However, the total BCAAs level was significantly decreased in diabetic patients with micro and macroalbuminuria. Other amino acid plasma levels as tyrosine, arginine, ornithine, glycine, and the total AAAs level were significantly decreased in all diabetic subgroups compared to controls. Significant positive correlations between total BCAAs, valine, leucine, isoleucine, serum insulin, glucose, and HOMA-IR values in the diabetic normoalbuminuria group were found. The use of altered PFAAs profile as a prognostic factor in T2DM patients at risk for microalbuminuria or macroalbuminuria might reduce or prevent the incidence of end-stage diabetic renal disease.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>30706418</pmid><doi>10.1007/s12010-019-02956-9</doi><tpages>14</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0273-2289 |
ispartof | Applied biochemistry and biotechnology, 2019-07, Vol.188 (3), p.854-867 |
issn | 0273-2289 1559-0291 |
language | eng |
recordid | cdi_proquest_miscellaneous_2179502183 |
source | SpringerLink Journals - AutoHoldings |
subjects | Amino acids Arginine Biochemistry Biomarkers Biotechnology Chain branching Chemistry Chemistry and Materials Science Citrulline Diabetes Diabetes mellitus Diabetes mellitus (non-insulin dependent) End-stage renal disease Glycine Insulin Insulin resistance Isoleucine Kidney diseases Leucine Nephropathy Ornithine Patients Phenylalanine Plasma Plasma levels Subgroups Tyrosine Valine |
title | The Profile of Plasma Free Amino Acids in Type 2 Diabetes Mellitus with Insulin Resistance: Association with Microalbuminuria and Macroalbuminuria |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T11%3A22%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Profile%20of%20Plasma%20Free%20Amino%20Acids%20in%20Type%202%20Diabetes%20Mellitus%20with%20Insulin%20Resistance:%20Association%20with%20Microalbuminuria%20and%20Macroalbuminuria&rft.jtitle=Applied%20biochemistry%20and%20biotechnology&rft.au=Saleem,%20Tahia&rft.date=2019-07-01&rft.volume=188&rft.issue=3&rft.spage=854&rft.epage=867&rft.pages=854-867&rft.issn=0273-2289&rft.eissn=1559-0291&rft_id=info:doi/10.1007/s12010-019-02956-9&rft_dat=%3Cproquest_cross%3E2179502183%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2174077596&rft_id=info:pmid/30706418&rfr_iscdi=true |